BioSpace News Archive

Business

PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023

PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that it will report its third quarter 2023 financial results and operational highlights before the open of the U.S. financial markets on Wednesday, November 8, 2023.

November 1, 2023
·
1 min read
Business

Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company redefining neuroscience drug development, announced financial results for the third quarter ended September 30, 2023 and provided a general business update.

November 1, 2023
·
9 min read
Drug Development

Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD

Clearside Biomedical, Inc. announced the completion of recruitment in its ODYSSEY Phase 2b clinical trial, a randomized, double-masked, parallel-group, active-controlled, multi-center study in participants with neovascular age-related macular degeneration.

November 1, 2023
·
7 min read
Pharm Country

Applied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7

Applied Therapeutics, Inc. today announced that it will host a Diabetic Cardiomyopathy (DbCM) expert forum with key opinion leaders on Tuesday, November 7, 2023 at 8:00 a.m. ET.

November 1, 2023
·
2 min read
BioMidwest

Celcuity To Present at Upcoming Stifel and Jefferies Investor Conferences

Celcuity Inc. today announced that Brian Sullivan, Chairman, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following investor conferences.

November 1, 2023
·
1 min read
Business

Ginkgo Bioworks Announces Date of Third Quarter 2023 Results Presentation

Ginkgo Bioworks today announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2023, on Wednesday, November 8, 2023, beginning at 5:30 p.m. ET.

November 1, 2023
·
1 min read
Business

Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2023 financial results.

November 1, 2023
·
39 min read
Deals

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company.

November 1, 2023
·
3 min read
Business

TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the third quarter ended September 30, 2023, along with recent company developments.

November 1, 2023
·
19 min read
Genetown

Enara Bio, ROME Therapeutics and Nucleome Therapeutics to Host 2nd Annual Dark Genome Symposium

Enara Bio, ROME Therapeutics and Nucleome Therapeutics, three leading biotechnology companies focused on developing novel medicines driven by insights into the dark genome, announced that they will host the 2nd Annual Dark Genome Symposium on November 13-14, 2023 at the Francis Crick Institute in London.

November 1, 2023
·
6 min read